RICHMOND, Va., Oct. 18, 2017 -- Kinsale Capital Group, Inc. (NASDAQ:KNSL) announced today that it will release financial results for the third quarter of 2017 after the market closes on Thursday, November 2, 2017.
The Company will host a conference call to discuss its results with analysts and investors on Friday, November 3, 2017, beginning at 9:00 a.m. (Eastern Time). The release will also be available on the Company’s website, www.kinsalecapitalgroup.com.
To access the conference call, dial (844) 239-5282, conference ID# 96128388, or via the Internet by going to www.kinsalecapitalgroup.com and clicking on the “Investor Relations” link. Please visit the website at least 15 minutes before the call to register and download and install any necessary audio software. A replay of the call will be available on the website until the close of business on January 3, 2018.
About Kinsale Capital Group
Kinsale Capital Group, Inc. is a specialty insurance group headquartered in Richmond, Virginia, focusing on the excess and surplus lines market.
For more information contact:
Kinsale Capital Group, Inc.
(804) 289-1272
[email protected]


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



